Finance

Lists
SPHRY:OTCMKTS
Starpharma Holdings ADR Representing 10 Ord Shs
USD 5,75
+1,77%
(+0,100) 1D
8 Okt., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SPHRY...
Open
USD 5,75
High
USD 5,75
Low
USD 5,75
Mkt. cap
405,38 m
Avg. vol.
1,28 k
Volume
1,02 k
52-wk high
USD 5,98
52-wk low
USD 1,75
Beta
1,03
Shares outstanding
47,97 m
No. of employees
50
Open
USD 5,75
High
USD 5,75
Low
USD 5,75
Mkt. cap
405,38 m
Avg. vol.
1,28 k
Volume
1,02 k
52-wk high
USD 5,98
52-wk low
USD 1,75
Beta
1,03
Shares outstanding
47,97 m
No. of employees
50
News stories
From web sources and news partners
About Starpharma Holdings ADR Representing 10 Ord Shs
CEOJackie Fairley
Employees50
Founded1997
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
5,58 m
5,58 m
756,50 k
756,50 k
Cost of goods sold
2,69 m
2,69 m
3,26 m
3,26 m
Cost of revenue
2,69 m
2,69 m
3,26 m
3,26 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,21 m
2,21 m
1,91 m
1,91 m
Operating expense
2,21 m
2,21 m
1,91 m
1,91 m
Total operating expenses
4,89 m
4,89 m
5,17 m
5,17 m
Operating income
683,50 k
683,50 k
-4,42 m
-4,42 m
Other non operating income
-
-
-
-
EBT including unusual items
683,50 k
683,50 k
-4,42 m
-4,42 m
EBT excluding unusual items
683,50 k
683,50 k
-4,42 m
-4,42 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
683,50 k
683,50 k
-4,42 m
-4,42 m
Net profit margin
12,25%
12,25%
-583,74%
-583,74%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
753,50 k
753,50 k
-4,34 m
-4,34 m
Gain or loss from assets sale
-
-
-10,50 k
-10,50 k
AI content may include mistakes. Learn more
Google-programme